n-3 Polyunsaturated Fatty Acids (PUFAs) in the Prevention of Atrial Fibrillation
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of n-3 PUFAs in addition to amiodarone
and renin-angiotensin-aldosterone system (RAAS) inhibitors on the maintenance of sinus rhythm
after electrical conversion in patients with persistent Atrial fibrillation (AF).
Phase:
Phase 3
Details
Lead Sponsor:
Azienda Ospedaliera Spedali Civili di Brescia Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia